1d
GlobalData on MSNHologic pockets CE mark for contrast biopsy softwareThe receipt of a CE mark in Europe for Affirm follows the software gaining US market clearance from the FDA in October 2020.
(Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...
Hologic Inc. closed 24.50% short of its 52-week high of $84.67, which the company reached on August 9th.
Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, which was first granted ...
New Mexico Educational Retirement Board cut its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.5% in ...
The dismantling of USAID has already had significant impact across the globe, including shuttering HIV clinics, stranding ...
Louisiana State Employees Retirement System decreased its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent 13F filing with ...
The health care sector is likely reacting to the uncertainty created by the effect of federal budget cuts now being ...
Investors in Hologic, Inc. HOLX need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $40.00 Call had some of the highest implied ...
Hologic, Inc. (NASDAQ:HOLX), a leading medical technology company specializing in women's health, diagnostics, and medical imaging systems, has been navigating a complex market landscape characterized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results